EUIPO The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.
Protect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark OMBYQ was filed as Word mark on 05/01/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/27/2014.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 012838702 |
| Application date | May 1, 2014 |
| Publication date | August 20, 2014 |
| Entry date | November 27, 2014 |
| Expiration date | May 1, 2024 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases and central nervous system diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia and endocrine diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders and liver diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders and reproductive system diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of sleep disorders and urological disorders; antidepressants; Diagnostic agents, preparations and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 4, 2023 | Extension, Notification of expiry of trade mark | ||
| April 5, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11012838702